Powered Intracapsular Tonsillectomy Aids Pediatric OSA

This article originally appeared here.
Share this content:
Powered Intracapsular Tonsillectomy Aids Pediatric OSA
Powered Intracapsular Tonsillectomy Aids Pediatric OSA

MONDAY, Jan. 4, 2016 (HealthDay News) -- Powered intracapsular tonsillectomy and adenoidectomy (PITA) improves severe obstructive sleep apnea (OSA) in pediatric patients, according to a study published online Dec. 30 in JAMA Otolaryngology-Head and Neck Surgery.

Nadia Mostovych, M.D., from Thomas Jefferson University in Philadelphia, and colleagues assessed the medical records of 70 children (56 percent boys; median age, 3.7 years) with severe OSA to evaluate the effectiveness of PITA based on polysomnographic parameters.

The researchers observed significant mean decreases in the postoperative apnea-hypopnea index (P < 0.001), obstructive apnea index (P < 0.001), obstructive apnea-hypopnea index (P < 0.001), arousal index (P < 0.001), percentage of total sleep time spent snoring (P = 0.001), and oxygen desaturation index of 4 percent or more (P < 0.001). There were significant increases noted in mean oxygen saturation (P < 0.001) and oxygen saturation nadir (P < 0.001).

"Results are comparable to those described for traditional electrocautery tonsillectomy and support the use of PITA for the treatment of severe OSA in children with adenotonsillar hypertrophy," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

WHO: Vaccine Hesitancy a Major Global Health Threat

WHO: Vaccine Hesitancy a Major Global Health Threat

Percentage of U.S. children 19 to 35 months who have not been vaccinated has quadrupled since 2001

FDA Down to 5 Weeks of Funding to Review New Drug Applications

FDA Down to 5 Weeks of Funding to ...

Agency cannot accept new fees or applications until the shutdown is over

FDA Approves First Generic Version of Epilepsy Drug Sabril

FDA Approves First Generic Version of Epilepsy Drug ...

Generic equivalents held to same vigorous manufacturing standards as brand-name drugs

is free, fast, and customized just for you!




Already a member?

Sign In Now »